Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GROC-Rev in Aggressive NHL
NCT01307592Phase 2Unknown
- Sponsor
- Auxilio Mutuo Cancer Center
- Start
- Feb 2011
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in non-Hodgkin lymphoma (NHL), sponsored by Auxilio Mutuo Cancer Center. Status: unknown.
02
Drugs
lenalidomide
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT01307592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01307592.